APLS - Apellis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

APLS is currently covered by 15 analysts with an average price target of $36.55. This is a potential upside of $33.43 (1071.47%) from yesterday's end of day stock price of $3.12.

Apellis Pharmaceuticals's activity chart (see below) currently has 529 price targets and 385 ratings on display. The stock rating distribution of APLS is 66.67% BUY, 29.63% HOLD and 3.7% SELL.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 67.23% of the time, taking 201.49 days on average.

Highest price target for APLS is $48, Lowest price target is $18, average price target is $36.55.

Most recent stock forecast was given by STEVEN SEEDHOUSE from CANTOR FITZGERALD on 15-May-2026. First documented stock forecast 04-Dec-2017.

Best performing analysts who are covering APLS - Apellis Pharmaceuticals:

Colleen Kusy Michael Ulz Elemer Piros Annabel Samimy Chris Howerton Matthew Luchini

Currently out of the existing stock ratings of APLS, 18 are a BUY (66.67%), 8 are a HOLD (29.63%), 1 are a SELL (3.7%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 15-May-2026

$31

6 months 3 days ago
(15-May-2026)

5/24 (20.83%)

$13.11 (73.28%)

332

Buy Since 20-Jan-2026

$41

$-0.03 (-0.07%)

$26

7 months 1 days ago
(17-Apr-2026)

17/20 (85%)

$0.1 (0.24%)

97

Buy Since 02-Apr-2026

$41

$-0.03 (-0.07%)

$31

7 months 16 days ago
(02-Apr-2026)

2/2 (100%)

$0.59 (1.46%)

26

Hold Since 01-Nov-2023

$41

$-0.03 (-0.07%)

$20

7 months 16 days ago
(02-Apr-2026)

14/18 (77.78%)

$0.59 (1.46%)

148

Buy Since 04-Dec-2017

$41

$-0.03 (-0.07%)

$44

7 months 17 days ago
(01-Apr-2026)

21/28 (75%)

$0.61 (1.51%)

201

Show more analysts

Please expand the browser size to see the chart

What is APLS (Apellis Pharmaceuticals) average time for price targets to be met?

On average it took 201 days for the stock forecasts to be reached, with an average price target met ratio of 67.23%.

Which analyst most recently updated their price target on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse

Which analyst has the most public recommendations on APLS (Apellis Pharmaceuticals)?

Steven Seedhouse works at CANTOR FITZGERALD and has 5 price targets and 3 ratings on APLS

Which analyst is the currently most bullish on APLS (Apellis Pharmaceuticals)?

Akash Tewari with the highest potential upside of $78.23

Which analyst is the currently most reserved on APLS (Apellis Pharmaceuticals)?

Laura Chico with the lowest potential downside of -$23.03
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?